UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000026197
Receipt number R000030067
Scientific Title A phase II trial of induction erlotinib followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 EGFR mutated non-small cell lung cancer.
Date of disclosure of the study information 2017/02/17
Last modified on 2017/06/01 16:58:16

No. Disposal Last modified on Item of update
1 Insert 2017/02/17 18:04:34
2 Update 2017/02/17 18:04:57 UMIN ID1
3 Update 2017/06/01 16:58:16 Anticipated trial start date